Atlas Trials

Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer

Clinical trial NCT07143097 · COMPLETED

Trial details

NCT number
NCT07143097
Sponsor
Beni-Suef University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Triple -Negative Breast Cancer
Start date
2021-11-01
Primary completion
2024-12-30
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.